论文部分内容阅读
目的:研究将常规疗法联合左西孟旦应用于脓毒症休克患者中的作用与效果.方法:选取82例,时间范围于2019年7月-2021年2月期间,于我院接收并对其进行治疗的脓毒症休克患者,根据不同治疗方式划分组别,行常规疗法的41例作为对照组,另行常规疗法联合左西孟旦的41例作为观察组,比较两组应用的效果.结果:(1)观察组的各项心功能指标显著优于对照组,P＜0.05.(2)治疗后,2组的各项感染指标显著低于治疗前,P＜0.05,但是,对比2组的各项感染指标没有显著性的差异,P＞0.05.结论:脓毒症休克治疗工作中应用常规疗法联合左西孟旦能够改善患者各项心功能指标,但是,对于降低各项感染指标不具有显著性的效果,不会对患者的预后带来影响,可推广.“,”Objective: To study the effect of conventional therapy combined with levosimendan in patients with septic shock. Methods: choose 82 cases, the time range in July 2019 - February 2021, in our hospital to receive and carries on the treatment of patients with sepsis shock, divided into categories according to different treatments, routine treatment of 41 cases as control group, routine therapy in combination with levosimendan 41 cases separately as observation group, compared two groups of the effect of the application. Results:(1) The indexes of heart function in observation group were significantly better than those in control group (P ＜ 0.05). (2) After treatment, the infection indexes of the two groups were significantly lower than before treatment (P ＜ 0.05), but there was no significant difference in the infection indexes between the two groups (P ＞ 0.05). Conclusions: The application of conventional therapy combined with levosimendan in the treatment of septic shock can improve the cardiac function indexes of patients, but it has no significant effect on reducing the infection indexes, and will not affect the prognosis of patients, so it can be popularized.